Immunostimulating complexes (ISCOMs) 
Introduction
Feline leukaemia virus (FeLV) belongs to the Retroviridae family, subfamily Oncovirinae. It has a worldwide distribution and may cause leukaemia in cats, but more often it causes an immunodeficiency syndrome. It is considered that the protective antigen is the glycosylated envelope protein with a molecular weight of 70 000 (gp70) 1. Like most other retroviruses, the envelope of FeLV is first formed as a precursor protein (gp85). This is cleaved with a trypsin or a trypsin-like cellular enzyme of gp70 and pl5E during intracellular transport to the plasma membrane before budding out with the virus particle. Gp70 being the peripheral part of the envelope protein, is to a great extent detached from the transmembrane protein p 15E and the virus particle, and is found in the cell culture medium; pl5E, however, remains integrated in the virus envelope.
Recently it was shown in an immunization experiment in cats by Osterhaus et al. 2.3 that gp70 integrated into an immunostimulating complex (ISCOM) 4 could induce protection to challenge infection in cats. The immunization experiment was extended to a larger experiment including 140 cats 3'5. In this experiment about 85% of the ISCOMimmunized cats developed virus-neutralizing antibodies, available vaccine developed neutralizing antibodies. It had earlier been shown by Essex et al. 6 and later by others 7.s that cats with neutralizing antibodies to FeLV do not develop disease, i.e. they have protective immunity to FeLV. It has also been shown with a monoclonal antibody that gp70 contains at least one neutralizing epitope and that this epitope is conserved in the three known serotypes.
In the present work we describe the preparation of ISCOMs containing FeLV gp70, and we characterize them as regards their morphology, their content of gp70, pl5E and a breakdown product of gp70 migrating as a 32000 molecular weight protein in an SDS-polyacrylamide gel electrophoresis. A preliminary immunization study in mice is also documented and the prospects of a vaccine are discussed.
Materials and methods

Materials
The detergent MEGA-10 (n-decanoyl-methyl glucamine) 9 was synthesized according to the method of Hildreth 1°. MEGA-10 was used as a 20% stock solution in water. Quil A 'Spikoside' was from Iscotec AB (LuleL Sweden). Quil A was used as a 10% stock solution in water. The crosslinker DTNP (dithiobis-m-nitropyridine) was used as a 0.2% stock solution in DMSO'. Antisera. A mouse monoclonal antibody (mAb) against gp702 was used in the detection and purification of gp70. A hyperimmune antiserum against pl5E from Raucher murine leukaemia virus was a generous gift from Dr Oswald Jarrett, Glasgow, Scotland.
Cells and virus.
The cat T-lymphoma cell line F42212 was used for the propagation of FeLV. Cells were grown in RPMI 1640 (The National Veterinary Institute, Sweden) supplemented with 10% fetal calf serum, 100 IU penicillin and 100 Ixg streptomycin m1-1. Cultures up to 5 litres were grown in Roller bottles or in Spinner culture flasks. Larger volumes of cultures were run in a fermenter equipment from Chemoferm AB, Sweden. Harvested cell culture fluid was freed from cells and cell debris by low-speed centrifugation at 4000 rev min -~ for 30 min in a Sorvall rotor GS3. The supernatant was collected and concentrated 10--15 times by ultrafiltration through a pellicon filter (Millipore PTMK 00005) with an exclusion limit of 300 000. From the concentrate the virus was sedimented at 20000revmin -1 for 2h at 10*C in a Kontron TFA 20 rotor. The virus pellet was suspended in 10 ml 0.5 ra Tris, 0.15 M NaCI pH 7.5 (TN) and layered over a 30% sucrose cushion. The virus was centrifuged at 28 000 rev min -~ for 2 h at 10°C in a Kontron TST 28.38 rotor. This step was avoided for some virus batches in an effort to minimize the loss of gp70, due to shearing forces during centrifugation. From the stock solution the crosslinker (DTNP) was added to a concentration of 0.02% and incubated for 30 min at room temperature to stabilize the binding of gp70 to the membrane anchoring part, p 15E.
Me~o~
Labelling of virus glycoproteins. To dividing F422 cells were added 400 ~tCi glucosamine (TRK.398, Amersham), in 250ml RPMI 1640 medium free from glucose and supplemented with 10% fetal calf serum, over 24 h.
Formation oflSCOM. This was essentially performed as described before 4. To a virus sample of approximately 200 mg in 8 ml TN, 0.9 ml of the stock solution of MEGA was added to a final concentration of 2% and left for 2 h at room temperature. The solubilized virus was layered on top of 10% sucrose in TN in a volume of 2 ml containing MEGA at a concentration of 0.2%, with a layer of 30% sucrose in TN underneath. The solubilized virus was centrifuged at 30 000 rev per min for 2h at 20"C in a TST.41.14 rotor. The top fraction consisting of the sample volume plus the 10% sucrose layer was collected and Quil A was added to a concentration of 0.1%. The mixture was extensively dialysed against TN.
SDS-polyacrylamide gel electrophoresis.
This was done in a 12% gel according to Laemmli 13. Western blots. These were done according to Towbin et al. ~4 Quantification ofgpTO. A quantitative dot-immunoblot using afffinity-purified gp70 and a monoclonal antigp70 antibody were used to determine the amount ofgp70 in virus and ISCOMs. In the dot-immunoblot analysis a nitrocellulose filter holder from Bio-Rad (USA) was used.
Fluorography. To analyse the glycoprotein content of a virus preparation, virus labelled with tritiated glucosamine was electrophoresed in SDS-PAGE gels and soaked in scintillator fluid (Amplify, Amersham, England). The gel was dried. The radioactivity pattern was analysed by fluorography using Kodak X-AR 5 film. Protein determination. This was performed by the method of Bradford ~5 using bovine serum albumin as standard.
ELISA. The ELISA ~6 was performed in microtitre Immunoplates I (Nunc, Roskilde, Denmark). The plates were coated overnight at 4"C with either highly purified gp70 at a concentration of 1 ~tgml -~ or with FeLV ISCOMs at a concentration of 3 ~tg ml -~ in 50 mM carbonate buffer pH 9.6. All washings were made with phosphate-buffered saline (150 mM, pH 7.5) containing 0.2% Tween-20 (PBS-Tween). The plates were blocked with 5% dried milk in PBS-Tween for 1 h at 37°C. Antisera were diluted in PBS-Tween and incubated for I h at 37 °C. Horseradish peroxidase conjugated rabbit anti-mouse and swine anti-rabbit (Dakopatts, Copenhagen, Denmark) were diluted 1:1000 in PBS-Tween and incubated for 1 h at 37 °C. The enzyme reactions were visualized with tetramethylbenzidine (0.19 mg ml -~) (Sigma, USA) and H202 (0.006%) in 0.1 ~ acetate buffer pH 6.0 and absorbance was measured at 450 nm with a Titertek Multiscan spectrophotometer (Flow Laboratories, Irvine, Scotland).
Electron-microscopic analysis. Samples of ISCOMs
were applied to hydrophilic, carbon-coated grids. For dialysis the specimens were placed upside down on microdroplets of 0.1 M phosphate buffer, pH 7.0 before negative staining with ammonium molybdate, pH 7.0. The specimens were studied in a Philips 300 electron microscope at 60 kV accelerating voltage to improve the contrast effect. Photographs were taken in through focal series with minimal beam exposure.
Results
Formation and characterization of FeL V ISCOMs
FeLV originating from the cat T-lymphoma cell line F422 was concentrated and enriched by centrifugation. The virus material was solubilized with the detergent MEGA and the envelope proteins were integrated into ISCOMs by the dialysis method.
Recovery. The amount of the envelope protein gp70 was estimated at different steps of purification by a quantitative dot-immunoblot method using a monoclonal antigp70 antibody with highly purified gp70 as a standard. The purification steps include: (1) concentration by ultrafiltration where little loss occurred; (2) sedimentation of virus by two centrifugations where most of the gp70 was lost, approximately 70% ; (3) the preparation of ISCOMs with a centrifugation and a dialysis procedure where an additional 20% of the gp70 was lost. The remainder is < 10°/0 of the amount ofgp70 of the starting material. The detailed results are given in Table 1 . 
Electron-microscopic evaluation of FeLV ISCOMs.
A relatively homogeneous population of ISCOM particles was observed by electron microscopy (Figure 4) , By Western blot analysis the transmembrane protein pl5E was detected in virus and ISCOMs using rabbit hyperimmune antiserum. Two bands were detected in the virus lysate, but in the ISCOM preparation only the 15 k band was visible (Figure 2 ).
ELISA analysis of FeLV ISCOMs. The FeLV
ISCOMs were tested as antigen in ELISA against a monoclonal antibody to gp70 and against a rabbit anti-serum to pl5E (Figure 3) . The reading was plotted against the recriprocal antibody dilutions expressed as a natural logarithm. The behaviour and the slope of the curves for the two antisera are similar, indicating equal amounts of pl 5E and gp70 in the ISCOM preparation. Immunization of mice with FeL V ISCOMs. In a preliminary study two sets of five mice were immunized with FeLV ISCOMs with a total protein dose of 0.3 and 3.0 I~g respectively. The gp70 content of FeLV ISCOMs in this study was estimated to be 5% of the total protein content corresponding to a dose of 15 and 150 ng of gp70 respectively.
The serum titres were tested against highly purified gp70 in an ELISA. Low but clear-cut serum titres were detected against gp70 by this assay. The end dilution titres for the two sets of mice after the first and second immunization were as shown in Figure 5 .
Discussion
Like most retroviruses, the peripheral and glycosylated part of the envelope protein gp70 of FeLV detaches from the anchoring and transmembrane part--pl 5E. This fact makes it difficult to isolate and to assemble gp70 to micelles, or to ISCOMs, by hydrophobic interactions to enhance its immunogenicity. The necessity of presenting immunogens in defined physical forms with multimeric presentation of the antigen has been reviewed 17. The most immunogenic of such complexes seems to be the ISCOM 18. However, an experimental ISCOM vaccine based on gp70 has already been shown to protect cats against challenge 2. This vaccine was essentially prepared as described here, with a high amount of starting material and a low yield.
From Table 1 it is evident that the major loss of gp70 antigen occurs during the centrifugation steps. The monomeric, highly water-soluble gp70, with a comparatively low sedimentation coefficient, is readily separated from the faster-sedimenting virus particle. The addition of DTNP, which is used with the intention of stabilizing disulphide linkage between plSE and gp7011, did not prevent a major loss of remaining gp70. In the procedure used here, DTNP had to be added after the first centrifugation to avoid precipitation. It might be worth testing whether DTNP is more useful if the first centrifugation is replaced with another concentration and purification step. The final recovery of gp70 (in our procedure for making ISCOM) was ~< 10% and virtually all losses occurred during the virus-isolation procedures, as found with the preparation of ISCOMs with gpS1 of bovine leukaemia virus19. Therefore, alternative methods for making immunogenic complexes based on hydrophobic interactions such as protein micelles or virosomes would not solve this problem. An efficient way to preclude described losses of gp70 is by use of an animal cell producing the complete envelope protein gp85, e.g. after transfection with an animal cell vector cloned with the env gene where the cleavage region of gp70 is deleted. The product of such a construct of the env gene for gpl60 of HIV was efficiently integrated into ISCOMs. The ISCOM preparation was analysed in PAGE and Western blot. In the PAGE the most prominent virus bands of virus proteins seem to be p l 5 and p27, while gp70 and pl 5E are less prominent. In the Western blot, on the other hand, gp70 and p15E respectively are readily recognized with a monoclonal antibody (gp70), which is recognizing a neutralizing epitope, and a polyclonal serum (pl5E). This antibody (anti-gp70) is, therefore, potentially useful as a quality control tool for this experimental vaccine, as described by Merza et al. 19 , who used neutralizing monoclonal antibodies to control an experimental BLV vaccine. The ISCOM preparation described here reacted also in ELISA with this antibody under a less denaturing condition than the Western blot. In the Western blot this antibody, as well as detecting a band migrating as a 70 kDa protein in the SDS-PAGE, also detected a 32 kDa band. This band was present both in the virus particle preparation and the ISCOM. It is probably a split or degradation product of gp702° and less is found in freshly prepared virus or ISCOMs than in older preparations. The other split product with an expected molecular weight of 30 000-40 000 has not yet been identified. FeLV ISCOMs comprising different proteins were analysed by electron microscopy by a size distribution of the ISCOM particles. Although somewhat flattened, as judged by different tilt projections in electron microscopy (Figure 4a ), a variation in diameter ( Figure  4b ) may reflect a variation in volumes of the ISCOMs. The proteins in the shell of the cage-like ISCOM were efficiently exposed.
Another interesting observation is that the antibody recognizing pl 5E recognized two bands in the virus preparation but not in the ISCOM. The additional band has a slightly higher molecular weight in SDS-PAGE and may represent a precursor protein to plSE, as described for murine leukaemia virus 21. The rabbit anti-Raucher pl 5E coprecipitates two proteins with estimated molecular weights of 12 kD and 15 kD. The presence of p l 5E was necessary for the coprecipitation with gp70. Virus preparations from F422 cells lacked p15E, but contained pl2E, and failed to coprecipitate gpT0 z2. This might explain the low yield of gp70 recovered from virus produced by F422 cells.
In a dilution experiment with the monoclonal antibody to gp70 and the antiserum to p15E, similar titration curves were obtained, which should indicate that the number of the two molecules were of the same magnitude. We would have expected the number ofp 15E molecules to exceed that of gp70 due to the great 19ss of gpT0.
The FeLV ISCOMs produced as described here, readily induced antibody to highly purified gp70 in mice (Figure 4 ) after two doses containing as little as 15 ng gp70. The specificity of the antibody was confirmed in Western blot. It would, of course, be interesting to test in the natural host, i.e. the cat. Such experiments are presented in a subsequent paper 5.
